NCT05060874

Brief Summary

It is recommended to screen ageing patients for sarcopenia, due to the increased risk of morbimortality if detected positive. According to the consensus of the European Working Group on Sarcopenia in Older People, the diagnosis of sarcopenia is based, among other things, on grip strength measurement. Our study will compare the performance of the new GRIPWISE digital device with the mechanical dynamometer JAMAR, the gold standard currently used to assess the grip strength. We propose to evaluate it in an elderly hospitalized population where the prevalence of sarcopenia is likely to be high due to the high prevalence of various chronic illness, notably oncological and cardiological ones. This cross-sectional study will include 348 patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
348

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2021

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2021

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

September 22, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 29, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 18, 2021

Completed
Last Updated

November 30, 2021

Status Verified

November 1, 2021

Enrollment Period

Same day

First QC Date

September 22, 2021

Last Update Submit

November 18, 2021

Conditions

Age-Related Sarcopenia

Keywords

agedinpatientshand strength

Outcome Measures

Primary Outcomes (1)

  • Comparison between Jamar® and Gripwise® values for grip strength measurement

    Intra-class correlation between the best values obtained with each device

    day1

Secondary Outcomes (4)

  • comparison according to the patient's position

    day1

  • number of attempt to reach the maximum value

    day1

  • factors influencing detected weakness

    day1

  • satisfaction using the devices

    day1

Study Arms (1)

single group

gripwise or jamar will be randomly assessed first

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodProbability Sample
Study Population

aged inpatients hospitalized in CAEN University Hospital

You may qualify if:

  • men and women aged 65 or over
  • affiliated to a health insurance
  • Francophone.

You may not qualify if:

  • \- refusal to participate
  • unable to communicate
  • unable to use both hands (dominant and non-dominant)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Caen University Hospital

Caen, France

Location

Study Officials

  • Bérengère Beauplet, MD

    Caen UH

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

September 22, 2021

First Posted

September 29, 2021

Study Start

September 1, 2021

Primary Completion

September 1, 2021

Study Completion

November 18, 2021

Last Updated

November 30, 2021

Record last verified: 2021-11

Locations

FR(1)